Literature DB >> 30206493

Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy.

Nikhil Yegya-Raman1, Wei Zou2, Ke Nie1, Jyoti Malhotra3, Salma K Jabbour1.   

Abstract

Radiation therapy (RT) represents an integral part of a multimodality treatment plan in the definitive, preoperative and postoperative management of non-small cell lung cancer (NSCLC). Technological advances in RT have enabled a shift from two-dimensional radiotherapy to more conformal techniques. Three-dimensional conformal radiotherapy (3DCRT), the current minimum technological standard for treating NSCLC, allows for more accurate delineation of tumor burden by using computed tomography-based treatment planning instead of two-dimensional radiographs. Intensity-modulated RT (IMRT) and proton therapy represent advancements over 3DCRT that aim to improve the conformity of RT and provide the possibility for dose escalation to the tumor by minimizing radiation dose to organs at risk. Both techniques likely confer benefits to certain anatomic subgroups of NSCLC requiring RT. This article reviews pertinent studies evaluating the use of IMRT and proton therapy in locally advanced NSCLC, and outlines challenges, indications for use, and areas for future research.

Entities:  

Keywords:  Non-small cell lung cancer (NSCLC); intensity-modulated radiation therapy (IMRT); proton therapy; three-dimensional conformal radiotherapy (3DCRT); toxicities

Year:  2018        PMID: 30206493      PMCID: PMC6123184          DOI: 10.21037/jtd.2018.07.29

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  130 in total

1.  The relative costs of proton and X-ray radiation therapy.

Authors:  M Goitein; M Jermann
Journal:  Clin Oncol (R Coll Radiol)       Date:  2003-02       Impact factor: 4.126

2.  Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.

Authors:  Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig; Louise Braban; Steven A Leibel; C Clifton Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-04       Impact factor: 7.038

3.  Dosimetric impact of intrafraction motion for compensator-based proton therapy of lung cancer.

Authors:  Li Zhao; George A Sandison; Jonathan B Farr; Wen Chien Hsi; X Allen Li
Journal:  Phys Med Biol       Date:  2008-06-03       Impact factor: 3.609

4.  Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.

Authors:  R Charles Nichols; Soon N Huh; Randal H Henderson; Nancy P Mendenhall; Stella Flampouri; Zuofeng Li; Harry J D'Agostino; J Davis Cury; Dat C Pham; Bradford S Hoppe
Journal:  Clin Lung Cancer       Date:  2011-04-27       Impact factor: 4.785

5.  Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapy.

Authors:  Matthew P Deek; Sinae Kim; Ning Yue; Rekha Baby; Inaya Ahmed; Wei Zou; John Langenfeld; Joseph Aisner; Salma K Jabbour
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 6.  Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Joe Y Chang; Salma K Jabbour; Dirk De Ruysscher; Steven E Schild; Charles B Simone; Ramesh Rengan; Steven Feigenberg; Atif J Khan; Noah C Choi; Jeffrey D Bradley; Xiaorong R Zhu; Antony J Lomax; Bradford S Hoppe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-01-23       Impact factor: 7.038

7.  Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.

Authors:  Judith A Christian; James L Bedford; Steve Webb; Michael Brada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-21       Impact factor: 7.038

8.  Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003.

Authors:  Michaela A Dinan; Lesley H Curtis; William R Carpenter; Andrea K Biddle; Amy P Abernethy; Edward F Patz; Kevin A Schulman; Morris Weinberger
Journal:  J Clin Oncol       Date:  2012-07-02       Impact factor: 44.544

Review 9.  A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.

Authors:  Vivek Verma; Mark V Mishra; Minesh P Mehta
Journal:  Cancer       Date:  2016-02-01       Impact factor: 6.860

10.  Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients.

Authors:  Stephanie L A Govaert; Esther G C Troost; Olga C J Schuurbiers; Lioe-Fee de Geus-Oei; Ariën Termeer; Paul N Span; Johan Bussink
Journal:  Radiat Oncol       Date:  2012-09-07       Impact factor: 3.481

View more
  6 in total

1.  A Multifunctional Hydrogel Delivers Gold Compound and Inhibits Human Lung Cancer Xenograft.

Authors:  Puiyan Lee; Chun-Nam Lok; Chi-Ming Che; Weiyuan John Kao
Journal:  Pharm Res       Date:  2019-03-08       Impact factor: 4.200

2.  Effect of Intensity Modulated Radiotherapy (IMRT) on the immunity, physical status and clinical effect of locally advanced NSCLC patients.

Authors:  Jun-Kai Xu
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

3.  Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy.

Authors:  Kevin X Liu; Kailan Sierra-Davidson; Kevin Tyan; Lawrence T Orlina; J Paul Marcoux; Benjamin H Kann; David E Kozono; Raymond H Mak; Abby White; Lisa Singer
Journal:  Radiother Oncol       Date:  2021-10-22       Impact factor: 6.280

4.  Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience.

Authors:  Nathan Y Yu; Todd A DeWees; Chenbin Liu; Thomas B Daniels; Jonathan B Ashman; Staci E Beamer; Dawn E Jaroszewski; Helen J Ross; Harshita R Paripati; Jean-Claude M Rwigema; Julia X Ding; Jie Shan; Wei Liu; Steven E Schild; Terence T Sio
Journal:  Adv Radiat Oncol       Date:  2019-08-21

Review 5.  Biology of Radiation-Induced Lung Injury.

Authors:  Soumyajit Roy; Kilian E Salerno; Deborah E Citrin
Journal:  Semin Radiat Oncol       Date:  2021-04       Impact factor: 5.934

6.  Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.

Authors:  Mark V Mishra; Rahul Khairnar; Søren M Bentzen; Gary Larson; Henry Tsai; Christopher Sinesi; Carlos Vargas; George Laramore; Carl Rossi; Lane Rosen; Mingyao Zhu; William Hartsell
Journal:  Clin Transl Radiat Oncol       Date:  2019-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.